Tau and amyloid PET tracers demonstrate potential to sharpen the diagnosis of Alzheimer’s disease and frontotemporal dementias.
An antibody against ApoE helps clear plaques and improves cognition in AD model mice.
Conformations of misfolded tau survive injection from one mouse to the next, a property shared by prions.
A single dose of a commonly prescribed antidepressant suppresses Aβ production in the human central nervous system.
Deep-brain stimulation of the nucleus basalis of Meynert appeared safe and tolerable for Alzheimer’s patients.
Death receptor role in Alzheimer's disease looks less likely than was originally thought following a high-profile paper in 2009.
A gene already well known to counteract aging appears to improve cognition.
People with Alzheimer’s disease and other dementias may benefit from creative activities, but hard studies are still lacking.
Known for helping form new memories, new neurons may be just as important for erasing old ones.
Resveratrol consumption failed to correlate with heart disease, inflammation, cancer, or even mortality in a community-based study. Are its benefits overstated?
Will an antibody signature make for a new Alzheimer’s diagnostic?
By paring back calcium signaling, researchers prevented signs of Alzheimer’s in mice carrying a presenilin mutation. Could the strategy work in humans?
MetLife rewards research on secretases, toxic Aβ transmission.
New twist to fluorescence-based microscopy lets scientists see up-close how Aβ aggregates in living cells.